Samsara BioCapital, LLC - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 87 filers reported holding DICE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,420,834
+62.2%
202,7730.0%1.65%
+37.7%
Q1 2023$5,809,446
-8.2%
202,7730.0%1.20%
-11.8%
Q4 2022$6,326,518
+23.1%
202,773
-20.0%
1.36%
+13.6%
Q3 2022$5,140,000
+30.7%
253,4660.0%1.20%
+14.3%
Q2 2022$3,934,000
-10.0%
253,466
+10.9%
1.05%
-4.6%
Q1 2022$4,371,000228,4661.10%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders